AstraZeneca (AZN LN) says Phase III tozorakimab data in COPD showed a 29%-34% reduction in exacerbations

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Robinhood (HOOD) strikes deal with Crypto.com in latest prediction-markets push, WSJ reports

Solvay (SOLB BB) reportedly in talks with One Investment Management about a potential strategic partnership for its rare earths business, reports Reuters

AstraZeneca (AZN LN) says Phase III tozorakimab data in COPD showed a 29%-34% reduction in exacerbations

China President Xi holds phone call with UK PM Burnham, reports Xinhua

US DoE closes up to USD 1.9bln loan to restart NextEra Energy's (NEE) Duane Arnold Energy centre

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free